PHYSICAL ACTIVITY AS A LIFESTYLE INTERVENTION IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): A NARRATIVE REVIEW OF HEPATIC AND CARDIOMETABOLIC OUTCOMES
Authors:
- Anna SzotASAnna Szot
- Michał BabiczMBMichał Babicz
- Kamil ChudzickiKCKamil Chudzicki
- Wiktor CzyżewskiWCWiktor Czyżewski
- Daria DanielczykDDDaria Danielczyk
- Natalia MalatyńskaNMNatalia Malatyńska
- Oliwer MűllerOMOliwer Műller
- Jagoda PałubskaJPJagoda Pałubska
- Katarzyna RosaKRKatarzyna Rosa
- Agata SłomaASAgata Słoma
Open Access
- 25 March 2026
- journal article
- review article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
Abstract
This narrative review synthesizes current evidence on physical activity and structured exercise in adults with metabolic dysfunction-associated steatotic liver disease (MASLD), with particular emphasis on aerobic exercise, resistance training, and high-intensity interval training (HIIT). The manuscript was prepared as a structured review of guideline documents, systematic reviews, meta-analyses, randomized controlled trials, and selected observational studies identified primarily through PubMed-based searching and full-text source analysis. Because the overlap between historical non-alcoholic fatty liver disease (NAFLD) and current MASLD populations is nearly complete, earlier NAFLD exercise studies were treated as directly relevant to present-day MASLD. The reviewed literature shows that exercise consistently reduces liver fat, improves cardiorespiratory fitness, enhances insulin sensitivity, and favorably modifies body composition and selected cardiovascular risk markers, often without clinically significant weight loss. Aerobic exercise remains the best-studied modality, but resistance training also appears effective and may be especially valuable in patients with low fitness or concern about muscle loss. HIIT seems feasible and potentially beneficial in selected patients when appropriately supervised. Evidence for direct histological or fibrosis-specific benefit is promising but less robust than the evidence for steatosis and cardiometabolic outcomes. Overall, the findings support physical activity as a central lifestyle intervention in MASLD and highlight the importance of individualized prescription, adherence support, and technology-assisted delivery in future practice.Keywords
This publication has 34 references indexed in Scilit:
- Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver diseaseJournal of Hepatology, 2024
- High-Intensity Interval Training is Safe, Feasible and Efficacious in Nonalcoholic Steatohepatitis: A Randomized Controlled TrialDigestive Diseases and Sciences, 2022
- NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASHHepatology, 2022
- Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver DiseaseDigestive Diseases and Sciences, 2020
- Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-AnalysisClinical Gastroenterology and Hepatology, 2020
- Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic reviewJournal of Hepatology, 2017
- Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled TrialClinical Gastroenterology and Hepatology, 2017
- Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver DiseaseJAMA Internal Medicine, 2016
- Effect of aerobic exercise training dose on liver fat and visceral adiposityJournal of Hepatology, 2015
- Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 randomized trial)Hepatology, 2013